FBW
Biotech

Why Lexicon is in ‘good shape to go crazy’: CEO

Lexicon CEO Michael Exton told Fierce how he set the company's development and financial pathway "on a very different trajectory."
Will Maddox May 13, 2026 10:50am
drawing of magnifying glass on a brain

Fosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset

May 13, 2026 9:15am
syneos-herov2-04302026png

MRD as a Decision Engine: Rethinking Oncology Trial Design

Brought to you by Syneos Health
vaccine sales

Valneva to lay off up to 15%, faces tough travel vaccine market

May 13, 2026 8:35am
New road

Takeda 0 for 4 against nausea and vomiting after axing asset

May 13, 2026 5:08am
Warren Biddle

Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS

May 12, 2026 4:27pm
More News

Icon opens Texas research unit and new satellite clinics

May 13, 2026 1:52pm
Fierce Pharma

FDA's embattled Marty Makary steps down as commissioner

May 12, 2026 2:30pm

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B

May 12, 2026 11:45am

Fierce Biotech Fundraising Tracker '26: Isomorphic & more

May 12, 2026 10:00am